Literature DB >> 24118397

Infiltrative recurrent eccrine spiradenoma of the anterior neck treated using Mohs micrographic surgery.

Rajib R Rahim1, Neil Rajan, James A A Langtry.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24118397      PMCID: PMC4065362          DOI: 10.1111/dsu.12328

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  5 in total

1.  Eccrine spiradenoma.

Authors:  D W KERSTING; E B HELWIG
Journal:  AMA Arch Derm       Date:  1956-03

2.  De novo malignant eccrine spiradenoma: a case report and review of the literature.

Authors:  Basil M Hantash; Joanna L Chan; Barbara M Egbert; Hayes B Gladstone
Journal:  Dermatol Surg       Date:  2006-09       Impact factor: 3.398

3.  Cylindroma treated by Mohs micrographic surgery.

Authors:  J S Lo; S N Snow; F E Mohs
Journal:  J Dermatol Surg Oncol       Date:  1991-11

4.  Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.

Authors:  Neil Rajan; John Burn; James Langtry; Maya Sieber-Blum; Christopher J Lord; Alan Ashworth
Journal:  J Pathol       Date:  2011-05-19       Impact factor: 7.996

5.  Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.

Authors:  Neil Rajan; James A A Langtry; Alan Ashworth; Catherine Roberts; Pam Chapman; John Burn; Alison H Trainer
Journal:  Arch Dermatol       Date:  2009-11
  5 in total
  2 in total

1.  Multiple Segmental Eccrine Spiradenoma with a Zosteriform Pattern: A Case Report and Literature Review.

Authors:  Fang Ren; Zhili Hu; Qingtao Kong; Hong Sang
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

2.  Malignant transformation of a spiradenoma with blaschkoïd pattern.

Authors:  Salma Salim; Hafsae Bounniyt; Mohammed El Amraoui; Asmae Benzekri; Karima Senouci; Badredine Hassam
Journal:  Clin Case Rep       Date:  2018-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.